Jonine L Bernstein

Jonine L Bernstein

UNVERIFIED PROFILE

Are you Jonine L Bernstein?   Register this Author

Register author
Jonine L Bernstein

Jonine L Bernstein

Publications by authors named "Jonine L Bernstein"

Are you Jonine L Bernstein?   Register this Author

91Publications

2921Reads

18Profile Views

Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.

Acta Oncol 2019 Nov 8;58(11):1581-1593. Epub 2019 Aug 8.

Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2019.1643915DOI Listing
November 2019

Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.

Breast Cancer Res Treat 2018 Nov 23;172(2):487-496. Epub 2018 Aug 23.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, Room 2061, New York, NY, 10017, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4916-6
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4916-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697118PMC
November 2018

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.

Int J Cancer 2018 08 25;143(4):823-830. Epub 2018 Mar 25.

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041161PMC
August 2018

Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.

J Clin Oncol 2018 05 5;36(15):1513-1520. Epub 2018 Apr 5.

Anne S. Reiner, Julia Sisti, Marinela Capanu, Mark Robson, Xiaolin Liang, Meghan Woods, and Jonine L. Bernstein, Memorial Sloan Kettering Cancer Center; Mark Robson, Cornell University; Roy Shore, New York University School of Medicine, New York, NY; Esther M. John, Cancer Prevention Institute of California, Fremont, and Stanford School of Medicine, Stanford; David V. Conti, Daniel O. Stram, and Duncan C. Thomas, University of Southern California, Los Angeles; Leslie Bernstein, City of Hope National Medical Center, Duarte, CA; Charles F. Lynch, University of Iowa, Iowa City, IA; Jennifer D. Brooks and Julia A. Knight, University of Toronto; Julia A. Knight, Sinai Health System, Toronto, Ontario, Canada; Lene Mellemkjær, Danish Cancer Society Research Center, Copenhagen, Denmark; John D. Boice, Vanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, Nashville, TN; Patrick Concannon, University of Florida, Gainesville, FL; Marc Tischkowitz, University of Cambridge, Cambridge, United Kingdom; David Duggan, Translational Genomics Research Institute, Phoenix, AZ; and Kathleen E. Malone, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959199PMC
May 2018

ATM, radiation, and the risk of second primary breast cancer.

Int J Radiat Biol 2017 10 27;93(10):1121-1127. Epub 2017 Jul 27.

b Genetics Institute and Department of Pathology, Immunology and Laboratory Medicine , University of Florida , Gainesville , FL , U.S.A.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/09553002.2017.1
Publisher Site
http://dx.doi.org/10.1080/09553002.2017.1344363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113688PMC
October 2017

Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.

Springerplus 2015 30;4:825. Epub 2015 Dec 30.

Cancer Prevention Institute of California, Fremont, CA USA ; Department of Health Research and Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-015-1642-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695460PMC
January 2016

Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer.

Cancer Med 2015 Sep 13;4(9):1432-9. Epub 2015 May 13.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567028PMC
September 2015

Germline mutations in shelterin complex genes are associated with familial glioma.

J Natl Cancer Inst 2015 Jan 7;107(1):384. Epub 2014 Dec 7.

Affiliations of authors: Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX (MNB, SNJ, HD, LL, JT, DMM, RAG); Codified Genomics, LLC, Houston, TX (MNB); Department of Pediatrics, Division of Hematology-Oncology, Dan L. Duncan Cancer Center (GNA, MMG, AAB, ST, YL, SEP, CCL, DWP, MLB) and Department of Neurosurgery (AJ), Baylor College of Medicine, Houston, TX; Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT (EBC); Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA (EBC); Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH (JBS); Department of Epidemiology and Biostatistics, Georgia State University School of Public Health, Atlanta, GA (DI); Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC (DI, JS); Department of Surgery, Duke University Medical Center, Durham, North Carolina (FAO); Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer (SS); Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel (SiS); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (CJ); Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK (RSH); Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN (RBJ, DL); Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY (SHO, JLB); Department of Neurology, NorthShore University HealthSystem, Evanston, IL (RTM); Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA (MRW, KMW); Department of Public Health Services, University of Alberta, Edmonton, Alberta, Canada (FGD); Departments of Neurology, Neurosurgery, and Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA (RL); Department of Biostatistics (Sa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296199PMC
January 2015

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Neuro Oncol 2014 Oct 9;16(10):1333-40. Epub 2014 Apr 9.

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden (U.A., C.W., B.S.M.); Computational Life Science Cluster (CLiC), Umeå University, Umeå, Sweden (C.W.); Department of Medical Biosciences, Pathology, Umeå University, Umeå Sweden (K.C.); Department of Oncology, Clinical Science, Lund University, Lund, Sweden (S.A., Å.B.); Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, Texas (G.N.A., M.L.B.); Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas (S.S.); Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas (C.C.L.); Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas (M.N.B.); School of Public Health, Yale University, New Haven, Connecticut (E.B.C.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (E.B.C.); Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (J.B.-S.); University of Southern California, Los Angeles, California (R.L.); Cancer Control and Prevention Program/Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina (D.I., J.S.); Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK (R.S.H.); Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center , New York, New York (J.L.B., S.H.O.); Mayo Comprehensive Clinic Cancer, Mayo Clinic, Rochester, Minnesota (R.B.J., D.H.L.); Department of Neurological Surgery, University of California, San Francisco, California (M.W.); School of Public Health, University of Alberta, Edmonton, Canada (F.G.D.); Department of Neurology, NorthShore University Health System, Evanston, Illinois (R.M.); Cancer Late Effects Research, Oncology, Finsencenteret, Rigshospitalet, University of Copenhagen and Head, Survivorship, Danish Cancer Society Research Center, Copenhagen, Denmark (C.J.)

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165415PMC
October 2014

Breast-cancer risk in families with mutations in PALB2.

N Engl J Med 2014 Aug;371(6):497-506

From the Departments of Public Health and Primary Care (A.C.A., D.B., A.L., D.F.E.) and Oncology (D.F.E.), Centre for Cancer Genetic Epidemiology, Department of Oncology (D.F.E.), and Department of Medical Genetics and National Institute for Health Research Cambridge Biomedical Research Centre (M.T.), University of Cambridge, and the Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrooke's Hospital (J.R., D.S., M.T.), Cambridge, and the Oncogenetics Team, Institute of Cancer Research and Royal Marsden National Health Service Foundation Trust, London (C.T., S.S., N.R.) - all in the United Kingdom; the Division of Medical Genetics, Department of Medicine, University of Washington, Seattle (S.C., M.-C.K.); the Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital (T.H., S.K., H.N.), and the Department of Clinical Genetics, Helsinki University Central Hospital (K.A.), Helsinki, the Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, and the Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Center NordLab, Oulu University Hospital (K.P., R.W.), and the Department of Clinical Genetics, University of Oulu and Oulu University Hospital (J.S.M.), Oulu, Biocenter Kuopio and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio (A.M.), and the Institute of Biomedical Technology-Cancer Genomics, University of Tampere, Tampere (A.K.) - all in Finland; the Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium (K.D.L., B.P., K.B.M.C.); the Molecular Diagnostics Laboratory, Institute of Nuclear and Radiologic Sciences and Technology, Energy and Safety, National Center for Scientific Research Demokritos, Athens (F.F., D.Y.); the Department of Genetics, Eastern Ontario Regional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa (E.T.), Samuel Lunenfeld Research

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1400382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157599PMC
August 2014

Breast cancer after chest radiation therapy for childhood cancer.

J Clin Oncol 2014 Jul 21;32(21):2217-23. Epub 2014 Apr 21.

Chaya S. Moskowitz, Joanne F. Chou, Suzanne L. Wolden, Jonine L. Bernstein, Danielle Novetsky Friedman, Nidha Z. Mubdi, Colin B. Begg, and Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center; Jyoti Malhotra, Mount Sinai Medical Center, New York, NY; Wendy M. Leisenring, Fred Hutchinson Cancer Research Center, Seattle, WA; Marilyn Stovall and Susan A. Smith, University of Texas MD Anderson Cancer Center, Houston, TX; Sue Hammond, Nationwide Children's Hospital, Columbus, OH; Tara O. Henderson, University of Chicago Medicine Comer Children's Hospital, Chicago, IL; John D. Boice, Vanderbilt-Ingram Cancer Center, Nashville; Melissa M. Hudson and Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; Lisa R. Diller and Lisa B. Kenney, Dana-Farber Cancer Institute, Boston, MA; Smita Bhatia, City of Hope National Medical Center, Duarte, CA; and Joseph P. Neglia, University of Minnesota Masonic Cancer Center, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4601DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100937PMC
July 2014

A conceptual and methodological framework for investigating etiologic heterogeneity.

Stat Med 2013 Dec 16;32(29):5039-52. Epub 2013 Jul 16.

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.5902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104361PMC
December 2013

Incorporating prior biologic information for high-dimensional rare variant association studies.

Hum Hered 2012 11;74(3-4):184-95. Epub 2013 Apr 11.

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90089, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000346021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058572PMC
October 2013

Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.

Cancer Epidemiol Biomarkers Prev 2012 Dec 2;21(12):2261-7. Epub 2012 Oct 2.

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 E 63rd Street, 2nd floor, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-12-1036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518741PMC
December 2012

Body mass index and risk of second primary breast cancer: the WECARE Study.

Breast Cancer Res Treat 2012 Jan 3;131(2):571-80. Epub 2011 Sep 3.

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 E 63rd Street, 3rd Floor, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1743-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251700PMC
January 2012

Background parenchymal enhancement at breast MR imaging and breast cancer risk.

Radiology 2011 Jul 14;260(1):50-60. Epub 2011 Apr 14.

Department of Radiology, Memorial Sloan-Kettering Cancer Center, Evelyn H. Lauder Breast Center, 300 E 66th St, Room 715, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.11102156DOI Listing
July 2011

Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.

Breast Cancer Res Treat 2011 Jun 15;127(3):819-29. Epub 2010 Dec 15.

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Harlyne J Norris Cancer Research Tower, 1450 Biggy Street Room 1509J, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1285-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234998PMC
June 2011

Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.

J Clin Oncol 2008 Mar 4;26(9):1411-8. Epub 2008 Feb 4.

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.3081DOI Listing
March 2008

Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.

Int J Radiat Oncol Biol Phys 2007 Nov 22;69(3):677-84. Epub 2007 May 22.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.04.012DOI Listing
November 2007

Reproductive history and risk of second primary breast cancer: the WECARE study.

Cancer Epidemiol Biomarkers Prev 2007 May;16(5):906-11

Epidemiology Division, Department of Medicine, University of California, Irvine, Irvine, CA 92697-7555, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-1003DOI Listing
May 2007

Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.

Cancer Epidemiol Biomarkers Prev 2006 Nov;15(11):2311-3

Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0176DOI Listing
November 2006

The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):348-52

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 3rd Floor, 307 East 63rd Street, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-05-0557DOI Listing
February 2006

Identification of mammaglobin as a novel serum marker for breast cancer.

Clin Cancer Res 2005 Sep;11(18):6528-35

Departments of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-0415DOI Listing
September 2005

The descriptive epidemiology of second primary breast cancer.

Epidemiology 2003 Sep;14(5):552-8

Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ede.0000072105.39021.6dDOI Listing
September 2003

Factors influencing mortality among young women with second primary breast carcinoma.

Cancer 2002 Nov;95(10):2051-8

Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.10950DOI Listing
November 2002

Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue.

Cancer Epidemiol Biomarkers Prev 2002 Sep;11(9):809-14

Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
September 2002